Cormorant Asset Management, LP RNA Holdings History
Cormorant Asset Management, LP's Avidity Biosciences Inc Holding Summary
As of 2025-03-31, Cormorant Asset Management, LP held 400,000.00 shares of Avidity Biosciences Inc(RNA), totaling $11.81 Mil. This investment constitutes 0.89% of their stock portfolio, and Cormorant Asset Management, LP now holds 0.33% of the outstanding Avidity Biosciences Inc(RNA) stock.
The initial trade took place in 2020Q3. And since then Cormorant Asset Management, LP has made 4 purchases of RNA, at an average price of $28.53, for a total of 4.31 Mil shares. In addition, there have been 8 sales at an average price of $13.95 for 3.91 Mil shares. Based on historical transaction data and RNA's current price of $33.76, Cormorant Asset Management, LP's estimated gain on his RNA holdings is $-54.98 Mil, reflecting a -44.66% gain to date.
Cormorant Asset Management, LP RNA ($33.76) Holding Chart
Cormorant Asset Management, LP RNA ($33.76) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
